Adjusting_the_dose_to_the_individual_response_of_the_patient_during_the_induction_of_ovulation_with_pulsatile_gonadotropin-releasing_hormone._To_identify_the_effective_dose_of_intravenous_pulsatile_gonadotropin-releasing_hormone_necessary_to_induce_ovulation_in_patients_with_chronic_anovulation_of_diverse_etiology,_40_women_were_subdivided_into_four_groups:_idiopathic_hypogonadotropic_hypogonadism_(IHH),_functional_hypothalamic_amenorrhea,_normoandrogenic_oligomenorrhea,_and_polycystic_ovarian_syndrome_(PCOS)._During_90_treatment_cycles,_the_dose_was_the_only_parameter_that_was_progressively_adjusted._The_overall_ovulation_rate_per_cycle_was_100%_in_IHH,_functional_hypothalamic_amenorrhea,_and_normoandrogenic_oligomenorrhea,_using_only_5_micrograms/90_minutes_in_functional_hypothalamic_amenorrhea_and_normoandrogenic_oligomenorrhea_and_up_to_7.5_micrograms/90_minutes_in_IHH._In_PCOS,_the_ovulation_rate_was_67.6%,_using_up_to_20_micrograms/90_minutes._The_lesser_degree_of_effectiveness_observed_in_PCOS_can_probably_be_explained_by_the_different_basal_endocrine_profile_presented_by_these_subjects.